Journal of Infection
Volume 54, Issue 2 , Pages e65-e68, February 2007

Rapid development of secondary sclerosing cholangitis due to vancomycin-resistant enterococci

  • Bodo Hoffmeister

      Affiliations

    • Department of Internal Medicine and Infectious Diseases, Charité University Hospital, Schumannstraße 20/21, 10117 Berlin, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 30 450 653 389; fax: +49 30 450 553 935.
  • ,
  • Johann Ockenga

      Affiliations

    • Department of Gastroenterology, Hepatology and Endocrinology, Charité University Hospital, Schumannstraße 20/21, 10117 Berlin, Germany
  • ,
  • Guido Schachschal

      Affiliations

    • Department of Gastroenterology, Hepatology and Endocrinology, Charité University Hospital, Schumannstraße 20/21, 10117 Berlin, Germany
  • ,
  • Norbert Suttorp

      Affiliations

    • Department of Internal Medicine and Infectious Diseases, Charité University Hospital, Schumannstraße 20/21, 10117 Berlin, Germany
  • ,
  • Joachim Seybold

      Affiliations

    • Department of Internal Medicine and Infectious Diseases, Charité University Hospital, Schumannstraße 20/21, 10117 Berlin, Germany

Accepted 7 April 2006.

Summary 

Secondary sclerosing cholangitis is a rare complication of acute bacterial cholangitis. The natural course of the disease is a slow progression over years. Here we report about a patient in whom sclerosing cholangitis evolved much faster as a consequence of a persistent biliary infection with vancomycin-resistant enterococci. The infection could be treated successfully with prolonged therapy with linezolid and teicoplanin. This is the first report of sclerosing cholangitis caused by vancomycin-resistant enterococci. It illustrates the rapidity with which this disease can evolve as a fulminant and ultimately fatal complication of acute bacterial cholangitis.

Keywords: Acute bacterial cholangitis, Secondary sclerosing cholangitis, Vancomycin-resistant enterococci, Linezolid

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0163-4453(06)00143-5

doi:10.1016/j.jinf.2006.04.004

Journal of Infection
Volume 54, Issue 2 , Pages e65-e68, February 2007